| Authors: |
Gaillard T; Department of Breast and Gynecological Surgery, Institut Curie, Université Paris Cité, Paris, France. thomas.gaillard@curie.fr., Piketty J; Department of Breast and Gynecological Surgery, Institut Curie, Université Paris Cité, Paris, France., Feron JG; Department of Breast and Gynecological Surgery, Institut Curie, Université Paris Cité, Paris, France., Girard N; Department of Breast and Gynecological Surgery, Institut Curie, Université Paris Cité, Paris, France., Pauly L; Department of Breast and Gynecological Surgery, Institut Curie, Université Paris Cité, Paris, France., Gauroy E; Department of Breast and Gynecological Surgery, Institut Curie, Université Paris Cité, Paris, France., Darrigues L; Department of Breast and Gynecological Surgery, Institut Curie, Université Paris Cité, Paris, France., Grandal B; Department of Breast and Gynecological Surgery, Institut Curie, Université Paris Cité, Paris, France.; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France., Pierga JY; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.; Department of Medical Oncology, Institut Curie, Université Paris Cité, Paris, France., Hamy-Petit AS; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.; Department of Medical Oncology, Institut Curie, Université Paris Cité, Paris, France., Reyal F; Department of Breast and Gynecological Surgery, Institut Curie, Université Paris Cité, Paris, France.; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France., Laas E; Department of Breast and Gynecological Surgery, Institut Curie, Université Paris Cité, Paris, France. |
